Trial intelligence / Profile preview

Intra-articular Tranexamic Acid with Different Drainage Clamping Times in ACL Reconstruction

NCT06280456Completed

Sponsor
Taipei Veterans General Hospital
Start
Sep 2022
Primary completion
Jan 2023
Modality
Small Molecules
Countries
1
01

Overview

Randomised, single-blind trial of tranexamic acid in postoperative hemorrhage and hemarthrosis (2 arms), sponsored by Taipei Veterans General Hospital. Primary endpoint: Volume of drainage at 1 day. Started Sep 2022; status: completed.

02

Drugs

tranexamic acid
03

Conditions

postoperative hemorrhagehemarthrosis

Beyond the preview

Go deeper on NCT06280456.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT06280456.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call